Literature DB >> 30683902

Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.

Nobuhide Higashino1,2, Yu-Ichiro Koma1, Masayoshi Hosono1,2, Nobuhisa Takase1,2, Maiko Okamoto1, Himiko Kodaira1, Mari Nishio1, Manabu Shigeoka1, Yoshihiro Kakeji2, Hiroshi Yokozaki3.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive tumor with frequent recurrence even after curative resection. The tumor microenvironment, which consists of non-cancer cells, such as cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), was recently reported to promote several cancers, including ESCC. However, the role of CAF as a coordinator for tumor progression in ESCC remains to be elucidated. In our immunohistochemical investigation of ESCC tissues, we observed that the intensity of expression of two CAF markers-alpha smooth muscle actin (αSMA) and fibroblast activation protein (FAP)-in the tumor stroma was significantly correlated with the depth of tumor invasion, lymph node metastasis, advanced pathological stage, and poor prognosis. We co-cultured human bone marrow-derived mesenchymal stem cells (MSCs) with ESCC cells and confirmed the induction of FAP expression in the co-cultured MSCs. These FAP-positive MSCs (which we defined as CAF-like cells) promoted the cell growth and migration of ESCC cells and peripheral blood mononuclear cell-derived macrophage-like cells. CAF-like cells induced the M2 polarization of macrophage-like cells. A cytokine array and ELISA revealed that CAF-like cells secreted significantly more CCL2, Interleukin-6, and CXCL8 than MSCs. These cytokines promoted the migration of tumor cells and macrophage-like cells. The silencing of FAP in CAF-like cells attenuated cytokine secretion. We compared cell signaling of MSCs, CAF-like cells, and FAP-silenced CAF-like cells; PTEN/Akt and MEK/Erk signaling were upregulated and their downstream targets, NF-κB and β-catenin, were also activated with FAP expression. Silencing of FAP attenuated these effects. Cytokine secretion from CAF-like cells were attenuated by inhibitors against these signaling pathways. These findings indicate that the collaboration of CAFs with tumor cells and macrophages plays a pivotal role in tumor progression, and that FAP expression is responsible for the tumor promotive and immunosuppressive phenotypes of CAFs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30683902     DOI: 10.1038/s41374-018-0185-6

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

1.  Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma.

Authors:  Liang Zhao; Yizhen Pang; Shanyu Chen; Jianhao Chen; Yimin Li; Yifeng Yu; Chunbin Huang; Long Sun; Hua Wu; Haojun Chen; Qin Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-12       Impact factor: 10.057

Review 2.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 3.  Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.

Authors:  Tongyan Liu; Chencheng Han; Siwei Wang; Panqi Fang; Zhifei Ma; Lin Xu; Rong Yin
Journal:  J Hematol Oncol       Date:  2019-08-28       Impact factor: 17.388

4.  CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.

Authors:  Hui Yang; Qiannan Zhang; Miao Xu; Lei Wang; Xuewei Chen; Yongquan Feng; Yongning Li; Xin Zhang; Wenming Cui; Xudong Jia
Journal:  Mol Cancer       Date:  2020-02-27       Impact factor: 27.401

Review 5.  The immune landscape of esophageal cancer.

Authors:  Tu-Xiong Huang; Li Fu
Journal:  Cancer Commun (Lond)       Date:  2019-11-26

Review 6.  CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.

Authors:  Jan Korbecki; Klaudyna Kojder; Donata Simińska; Romuald Bohatyrewicz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

7.  Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma.

Authors:  Fei-Yu Diao
Journal:  Thorac Cancer       Date:  2020-07-19       Impact factor: 3.500

8.  Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.

Authors:  Shuhai Chen; Yuji Morine; Kazunori Tokuda; Shinichiro Yamada; Yu Saito; Masaaki Nishi; Tetsuya Ikemoto; Mitsuo Shimada
Journal:  Int J Oncol       Date:  2021-07-01       Impact factor: 5.650

9.  High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.

Authors:  Mairene Coto-Llerena; Caner Ercan; Venkatesh Kancherla; Stephanie Taha-Mehlitz; Serenella Eppenberger-Castori; Savas D Soysal; Charlotte K Y Ng; Martin Bolli; Markus von Flüe; Guillaume P Nicolas; Luigi M Terracciano; Melpomeni Fani; Salvatore Piscuoglio
Journal:  Front Oncol       Date:  2020-07-08       Impact factor: 6.244

10.  Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss.

Authors:  Yaqian Hu; Long Wang; Zhuojie Zhao; Weiguang Lu; Jing Fan; Bo Gao; Zhuojing Luo; Qiang Jie; Xiaojuan Shi; Liu Yang
Journal:  Mol Med Rep       Date:  2020-09-28       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.